ArticleGynecology and pelvic medicine2026

Treatment of recurrent low grade serous ovarian cancer: MEK inhibition and the RAMP 201 trial.

Maryam Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.